Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Transplantation and cellular therapy [Transplant Cell Ther] NLMUID: 101774629"" wg kryterium: JN


Tytuł:
Long Term Follow-Up Of Abatacept, Post-Transplantation Cyclophosphamide and Sirolimus (AbaCyS) based Haploidentical Transplantation in Younger Patients with Nonmalignant Diseases.
Autorzy:
Jaiswal SR; Department Of Blood and Marrow Transplantation, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi,; Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, Kolkata, India; Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India. Electronic address: .
Agarwal M; Department Of Blood and Marrow Transplantation, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi,; Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, Kolkata, India.
Bhagawati G; Department Of Microbiology, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi.
Das BC; Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India.
Baligar P; Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India.
Garg M; Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India.
Biswas S; Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India.
Chakrabarti S; Department Of Blood and Marrow Transplantation, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi,; Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, Kolkata, India; Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 13. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Treatment Sensitive and Treatment Dependent Chronic GVHD Yield Superior Failure Free and Overall Survival Compared to Treatment Resistant Chronic GVHD.
Autorzy:
Jurdi NE; Blood and Marrow Transplant Program, University of Minnesota; Department of Medicine, University of Minnesota. Electronic address: .
Herzog S; Blood and Marrow Transplant Program, University of Minnesota; Department of Medicine, University of Minnesota.
Shanley R; Biostatistics Core, University of Minnesota Masonic Cancer Center.
Holtan SG; Blood and Marrow Transplant Program, University of Minnesota; Department of Medicine, University of Minnesota.
MacMillan ML; Department of Medicine, University of Minnesota; Department of Pediatrics, University of Minnesota.
Weisdorf DJ; Blood and Marrow Transplant Program, University of Minnesota; Department of Medicine, University of Minnesota.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 11. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Pre-transplant blinatumomab improves outcomes in B-cell acute lymphoblastic leukemia patients who undergo allogeneic hematopoietic cell transplantation.
Autorzy:
Sayyed A; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada.
Chen C; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada.
Gerbitz A; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Kim DDH; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Kumar R; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Lam W; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Law AD; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Lipton JH; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Michelis FV; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Novitzky-Basso I; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Viswabandya A; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Mattsson J; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Pasic I; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 08. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Increased PD-1 expression on circulating T-cells correlates with inferior outcome after autologous stem cell transplantation.
Autorzy:
Richter S; Department of Internal Medicine 5, Hematology and Clinical Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.
Böttcher M; Department of Hematology and Oncology, Otto-von-Guericke-University (OVGU) Magdeburg, University Hospital, Magdeburg, Germany; Health Campus Immunology, Infectiology, and Inflammation, Medical Center, Otto-von-Guericke University (OVGU) Magdeburg, Magdeburg, Germany.
Stoll A; Department of Internal Medicine 5, Hematology and Clinical Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.
Zeremski V; Department of Hematology and Oncology, Otto-von-Guericke-University (OVGU) Magdeburg, University Hospital, Magdeburg, Germany; Health Campus Immunology, Infectiology, and Inflammation, Medical Center, Otto-von-Guericke University (OVGU) Magdeburg, Magdeburg, Germany.
Völkl S; Department of Internal Medicine 5, Hematology and Clinical Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
Mackensen A; Department of Internal Medicine 5, Hematology and Clinical Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
Ekici AB; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Jacobs B; Department of Internal Medicine 5, Hematology and Clinical Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
Mougiakakos D; Department of Hematology and Oncology, Otto-von-Guericke-University (OVGU) Magdeburg, University Hospital, Magdeburg, Germany; Health Campus Immunology, Infectiology, and Inflammation, Medical Center, Otto-von-Guericke University (OVGU) Magdeburg, Magdeburg, Germany. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 07. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP trial.
Autorzy:
Prete A; Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Lanino E; Hematopoietic Stem Cell Transplantation Unit, IRCSS Istituto Giannina Gaslini, Genoa, Italy.
Saglio F; Pediatric Oncohematology, Stem Cell Transplantation and Cell Therapy Division, A.O.U. Città della Salute e della Scienza-Regina Margherita Children's Hospital, Turin, Italy.
Biffi A; Pediatric Hematology, Oncology and Stem Cell Transplant Division, University-Hospital of Padua, Padua, Italy.
Calore E; Pediatric Hematology, Oncology and Stem Cell Transplant Division, University-Hospital of Padua, Padua, Italy.
Faraci M; Hematopoietic Stem Cell Transplantation Unit, IRCSS Istituto Giannina Gaslini, Genoa, Italy.
Rondelli R; Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Favre C; Department of Pediatric Hematology/Oncology and Hematopoietic Stem Cell Transplantation, Meyer Children's University Hospital, Florence, Italy.
Zecca M; Department of Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Casazza G; Oncoematologia Pediatrica, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Porta F; Pediatric Oncohematology and Bone Marrow Transplant Unit, Children's Hospital, ASST Spedali Civili of Brescia, Brescia, Italy.
Luksch R; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Cesaro S; Pediatric Hematology Oncology Unit, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Rabusin M; Department of Pediatrics, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
Parasole R; Department of Pediatric Hemato-Oncology and cellular therapy, Azienda sanitaria di rilievo nazionale Santobono-Pausilipon, Napoli, Italy.
Mura RM; Pediatric Oncology Unit, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Nigro LL; Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Azienda Policlinico 'G. Rodolico - San Marco', Catania, Italy.
Leardini D; Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: .
Pagliara D; Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Locatelli F; Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy.
Fagioli F; Pediatric Oncohematology, Stem Cell Transplantation and Cell Therapy Division, A.O.U. Città della Salute e della Scienza-Regina Margherita Children's Hospital, Turin, Italy; University of Turin, Turin, Italy.
Pokaż więcej
Corporate Authors:
AIEOP-BMT Group
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 07. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Nutritional strategies to improve VRE control.
Autorzy:
Morello E; Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, 25123, Brescia, Italy. Electronic address: .
Roversi S; Institute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy, 25123, Brescia, Italy.
Brambilla G; Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, 25123, Brescia, Italy.
Signorini L; Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Lorenzoni M; Medical Direction of the Civil Hospitals of Brescia, ASST-Spedali Civili Brescia, 25123, Brescia, Italy.
Andreoli M; Dietetics and Clinical Nutrition Unit, ASST-Spedali Civili Brescia, 25123, Brescia, Italy.
Bernardi S; Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, 25123, Brescia, Italy.
Malagola M; Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, 25123, Brescia, Italy.
Farina M; Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, 25123, Brescia, Italy.
Radici V; Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, 25123, Brescia, Italy.
Magliano G; Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, 25123, Brescia, Italy.
Fiorentini S; Institute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy, 25123, Brescia, Italy.
Caruso A; Institute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy, 25123, Brescia, Italy.
Russo D; Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, 25123, Brescia, Italy.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 07. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Early CAR-T Cells expansion is associated with prolonged PFS for patients with RRMM treated with ide-cel: a retrospective monocentric study.
Autorzy:
Caillot L; Hematologie Clinique, CHU Dijon, Dijon, France.
Sleiman E; Hematologie Clinique, CHU Dijon, Dijon, France.
Lafon I; Hematologie Clinique, CHU Dijon, Dijon, France; Institut de Cancérologie de Bourgogne, Dijon, France.
Chretien ML; Hematologie Clinique, CHU Dijon, Dijon, France; Institut de Cancérologie de Bourgogne, Dijon, France.
Gueneau P; Unite Therapie Innovante, Pharmacie, CHU Dijon, Dijon, France.
Payssot A; Hematologie, Clinique du Parc, Castelnau Le Lez, France.
Pedri R; Hematologie Clinique, CHU Dijon, Dijon, France.
Lakomy D; Laboratoire de Biochimie Spécialisée, CHU Dijon, Dijon, France.
Bailly F; Laboratoire d'Hematologie, CHU Dijon, Dijon, France.
Guy J; Laboratoire d'Hematologie, CHU Dijon, Dijon, France.
Quenot JP; Medecine Intensive et Reanimation, CHU Dijon, Dijon, France.
Avet-Loiseau H; Unite de Genomique du Myelome, IUCT Oncopole, Toulouse, France.
Caillot D; Hematologie Clinique, CHU Dijon, Dijon, France; Institut de Cancérologie de Bourgogne, Dijon, France. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 06. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report from the BMT CTN Infectious Disease Technical Committee.
Autorzy:
Shahid Z; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address: .
Etra AM; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Levine JE; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Riches ML; Center for International Blood and Marrow Transplantation Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Baluch A; Division of Infectious Diseases, Moffitt Cancer Center, Tampa, FL.
Hill JA; Department of Medicine, University of Washington, WA and Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
Nakamura R; Division of Hematology and HCT, City of Hope, Duarte, CA.
Toor AA; Lehigh Valley Health Network, Allentown, PA.
Ustun C; Division of Hematology, Oncology and Cell Therapy, Section of Bone Marrow Transplantation and Cellular Therapy, Rush Medical College, Chicago, IL.
Young JH; Department of Medicine, Division of Infectious Disease and International Medicine, Program in Adult Transplant Infectious Disease, University of Minnesota, Minneapolis, MN.
Perales MA; Department of Medicine, Weill Cornell Medical College, New York, NY; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center; Weill Cornell Medical College, New York, NY.
Epstein DJ; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 06. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Gut immunomodulation with vedolizumab prior to allogeneic hematopoietic stem cell transplantation in pediatric patients with inflammatory bowel disease.
Autorzy:
Chopra Y; Division of Hematology/Oncology, Blood and Marrow Transplant/Cellular Therapy, Hospital for Sick Children, Toronto, ON. Electronic address: .
Acevedo K; Division of Hematology/Oncology, Blood and Marrow Transplant/Cellular Therapy, Hospital for Sick Children, Toronto, ON.
Muise A; Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, Toronto, ON.
Frost K; Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, Toronto, ON.
Schechter T; Division of Hematology/Oncology, Blood and Marrow Transplant/Cellular Therapy, Hospital for Sick Children, Toronto, ON.
Krueger J; Division of Hematology/Oncology, Blood and Marrow Transplant/Cellular Therapy, Hospital for Sick Children, Toronto, ON.
Ali M; Division of Hematology/Oncology, Blood and Marrow Transplant/Cellular Therapy, Hospital for Sick Children, Toronto, ON.
Chiang KY; Division of Hematology/Oncology, Blood and Marrow Transplant/Cellular Therapy, Hospital for Sick Children, Toronto, ON.
Kim VY; Division of Immunology and Allergy, Hospital for Sick Children, Toronto, ON.
Grunebaum E; Division of Immunology and Allergy, Hospital for Sick Children, Toronto, ON.
Wall D; Division of Hematology/Oncology, Blood and Marrow Transplant/Cellular Therapy, Hospital for Sick Children, Toronto, ON.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 06. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Long-Term Clinical Outcomes and B Cell Immune Reconstitution following Allo-HCT with Prophylactic, Post-Transplant Rituximab.
Autorzy:
Kennedy VE; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: .
Sahaf B; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
Wu F; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
Ehlinger ZJ; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
Arai S; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
Miklos DB; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 06. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Umbilical Cord Blood Transplantation for Fanconi Anemia with a special focus on late complications: a Study on Behalf of Eurocord and SAAWP-EBMT.
Autorzy:
Rafii H; Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Hôpital Saint-Louis, Université Paris Cité, Paris, France.
Volt F; Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Hôpital Saint-Louis, Université Paris Cité, Paris, France.
Bierings M; Princess Maxima Center, University Hospital for Children, Utrecht, Netherlands.
Dalle JH; Robert Debré Hospital, Pediatric Hematology and Immunology Department, Université Paris Cité, APHP, Paris, France.
Ayas M; King Faisal Specialist Hospital and Research Center, Department of Pediatric Hematology Oncology, Riyadh, Saudi Arabia.
Rihani R; King Hussein Cancer Centre, Pediatric Blood, Marrow and Cellular Therapy Program, Amman, Jordan.
Faraci M; Hematopoetic Stem Cell Unit, Department of Hematology-Oncology, IRCCS Istituto G. Gaslini, Genova, Italy.
de Simone G; Unità Operativa Complessa di Trapianto di Cellule Staminali Ematopoietiche e Terapie Cellulari, Azienda Ospedaliera di Rilievo Nazionale Santobono-Pausilipon, Napoli, Italy.
Sengeloev H; Bone Marrow Transplant Unit L 4043, National University Hospital, Copenhagen, Denmark.
Passweg J; University Hospital of Basel, Hematology Department, Basel, Switzerland.
Cavazzana M; Hôpital Necker, Centre Imagine, Paris, France.
Costello R; Centre Hospitalier Universitaire La Conception, Marseille France.
Maertens J; University Hospital Gasthuisberg Departement of Hematology, Leuven, Belgium.
Biffi A; Pediatric Hematology, Oncology and Stem Cell Transplant division, Padua University Hospital, Padua, Italy.
Johansson JE; Sahlgrenska University Hospital, Goteborg, Sweden.
Montoro J; University Hospital La Fe, Valencia, Spain.
Guepin GR; Service hématologie, CHRU Nancy, France.
Diaz MA; Niño Jesus Children`s Hospital, Servicio de Hematologia, Madrid, Spain.
Sirvent A; CHU -A de Villeneuve, Pediatric Onco-Hematology unit, Montpellier, France.
Kenzey C; Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Hôpital Saint-Louis, Université Paris Cité, Paris, France.
Rivera Franco MM; Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Hôpital Saint-Louis, Université Paris Cité, Paris, France.
Cappelli B; Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Hôpital Saint-Louis, Université Paris Cité, Paris, France; Monacord, Centre Scientifique de Monaco, Monaco.
Scigliuolo GM; Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Hôpital Saint-Louis, Université Paris Cité, Paris, France; Monacord, Centre Scientifique de Monaco, Monaco.
Rocha V; Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Hôpital Saint-Louis, Université Paris Cité, Paris, France; Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas, Faculty of Medicine, São Paulo University, São Paulo, Brazil.
Ruggeri A; Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Hôpital Saint-Louis, Université Paris Cité, Paris, France; Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy Cellular therapy and immunobiology working party of the EBMT.
Risitano A; University of Naples, Avellino, Italy; A.O.R.N. San Giuseppe Moscati, Avellino, Italy.
De Latour RP; Bone Marrow Transplant Unit, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Gluckman E; Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Hôpital Saint-Louis, Université Paris Cité, Paris, France; Monacord, Centre Scientifique de Monaco, Monaco. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 05. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy.
Autorzy:
Adams C; Gates Institute, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Keller M; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC; GW Cancer Center, George Washington University, Washington, DC.
Michlitsch JG; UCSF Benioff Children's Hospital Oakland, Oakland, California.
Aguayo-Hiraldo P; Children's Hospital of Los Angeles, Los Angeles, California.
Chen K; Seattle Children's Hospital, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington.
Hossain MZ; Seattle Children's Hospital, Seattle, Washington.
Davis A; Seattle Children's Hospital, Seattle, Washington.
Park JR; Seattle Children's Hospital, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; St Jude Children's Research Hospital, Memphis, Tennessee.
Verneris MR; Gates Institute, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Gardner RA; Seattle Children's Hospital, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; St Jude Children's Research Hospital, Memphis, Tennessee. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 04. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients following Treatment with Haploid Hematopoietic Stem Cell Transplantation using Modified Post-transplantation Cyclophosphamide.
Autorzy:
Fu A; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Peng Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Cheng P; Department of Hematology, Wuhan First People's Hospital, Wuhan 430030, China.
Wu J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhu X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Yang Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Wang N; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Wang J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Xu J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Wan Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Cao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Wei J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Xiao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Meng F; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: .
Cheng H; Department of Hematology, Wuhan First People's Hospital, Wuhan 430030, China.
Zhang Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhang D; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar 04. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Fragile Warriors: Navigating the Delicate Dance of Frailty and CAR-T cell Therapy for Relapsed/Refractory Multiple Myeloma.
Autorzy:
Friend R; Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Department of Internal Medicine, Wake Forest University School of Medicine, Charlotte, NC. Electronic address: .
Atrash S; Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Department of Internal Medicine, Wake Forest University School of Medicine, Charlotte, NC.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar; Vol. 30 (3), pp. 253-254.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
When four is more - improved COVID-19 antibody responses with 4 doses of vaccine in CAR T-cell therapy recipients.
Autorzy:
Hall VG; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar; Vol. 30 (3), pp. 250-252.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Long-Term Follow-Up for Recipients of Genetically Modified Cells: A Team Effort.
Autorzy:
Heslop HE; Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar; Vol. 30 (3), pp. 247-249.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study.
Autorzy:
Onozawa M; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan. Electronic address: .
Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Hashimoto H; Clinical Research Management Center, Nagoya City University Hospital, Nagoya, Japan.
Okada K; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
Tamaki M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Tanaka M; Department of Hematology and Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Sato T; Department of Haematology Oncology, Kurashiki Central Hospital, Kurashiki, Japan.
Takahashi T; Department of Hematology, Shimane University Hospital, Izumo, Japan.
Hatano K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Onodera K; Department of Hematology, Tohoku University Hospital, Sendai, Japan.
Moriuchi Y; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
Yakushijin K; Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan.
Kanda J; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
Nagafuji K; Department of Hematology and Oncology, Kurume University Hospital, Kurume, Japan.
Ogata M; Department of Hematology, Oita University Hospital, Yufu, Japan.
Nakano N; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Tamori A; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Mizokami M; Genome Medical Sciences Project, National Center for Global Health and Medicine, Ichikawa, Japan.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar; Vol. 30 (3), pp. 330.e1-330.e8. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell Transplantation.
Autorzy:
Shimomura Y; Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Chuo-ku, Kobe, Japan; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan. Electronic address: shimomura_.
Kitamura T; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Murata M; Department of Hematology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Matsuo K; Division Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Chikusa-ku, Nagoya Japan.
Ito Y; Department of Medical Statistics, Research & Development Center, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
Ichinohe T; Department of Hematology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Minami-ku, Hiroshima, Japan.
Hashii Y; Department of Pediatrics, Osaka International Cancer Institute, Chuo-ku, Osaka, Japan.
Goto H; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo-shi, Hokkaido, Japan.
Kato K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Higashi-ku, Fukuoka, Japan.
Ishimaru F; Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Atsugi, Kanagawa, Japan.
Sato A; Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Miyagi, Japan.
Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Yanagisawa A; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Aichi, Japan.
Ohbiki M; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Aichi, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Tabuchi K; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Aichi, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Aichi, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar; Vol. 30 (3), pp. 326.e1-326.e14. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
Autorzy:
Schoettler ML; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: .
Patel S; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Bryson E; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Deeb L; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Watkins B; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Qayed M; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Chandrakasan S; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Fitch T; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Silvis K; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Jones J; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Chonat S; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Williams KM; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar; Vol. 30 (3), pp. 336.e1-336.e8. Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients.
Autorzy:
Mumby P; Department of Psychiatry and Behavioral Neurosciences, Loyola University Medical Center, Maywood, Illinois. Electronic address: .
Adams W; Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.
Smith S; Parexel International, Hinsdale, Illinois.
Rao M; Department of Psychiatry and Behavioral Neurosciences, Loyola University Medical Center, Maywood, Illinois.
Stiff P; Department of Hematology and Oncology, Loyola University Medical Center Maywood, Illinois.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar; Vol. 30 (3), pp. 320.e1-320.e11. Date of Electronic Publication: 2023 Dec 24.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies